Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Finlay, A.Y.
665  Ergebnisse:
Personensuche X
?
1

Quality of life measurement in urticaria: Position statemen..:

Chernyshov, P. V. ; Finlay, A. Y. ; Tomas‐Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Mapping of Family Reported Outcome Measure (FROM-16) scores..:

Shah, R. ; Salek, M. S. ; Finlay, A. Y....
Quality of Life Research.  33 (2024)  4 - p. 1107-1119 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Responsiveness and minimal important change of the Family R..:

Shah, R. ; Finlay, A.Y. ; Salek, M.S....
Journal of Patient-Reported Outcomes.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
4

Measurement of the major ignored burden of multiple myeloma..:

Shah, R. ; Finlay, A. Y. ; Ali, F. M....
European Journal of Haematology.  113 (2024)  1 - p. 117-126 , 2024
Link: https://doi.org/10.1111/..
 
?
5

Dermatological patients with itch report more stress, stigm..:

Zeidler, C. ; Kupfer, J. ; Dalgard, F. J....
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
6

Quality of life measurement in rosacea. Position statement ..:

Chernyshov, P. V. ; Finlay, A. Y. ; Tomas‐Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  5 - p. 954-964 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Quality of life measurement in teledermatology. Position st..:

Chernyshov, P. V. ; Finlay, A. Y. ; Tomas‐Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  2 - p. 254-264 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Secukinumab improves the quality‐of‐life of family members ..:

Finlay, A. Y. ; Barker, J. N. ; Burden, A. D....
JEADV Clinical Practice.  1 (2022)  3 - p. 207-218 , 2022
Link: https://doi.org/10.1002/..
 
?
9

Impact of childhood atopic dermatitis on life decisions for..:

Capozza, K. ; Schwartz, A. ; Lang, J.E....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  6 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
10

Quality of life measurement in alopecia areata. Position st..:

Chernyshov, P.V. ; Tomas‐Aragones, L. ; Finlay, A.Y....
Journal of the European Academy of Dermatology and Venereology.  35 (2021)  8 - p. 1614-1621 , 2021
Link: https://doi.org/10.1111/..
 
?
11

Family reported outcomes, an unmet need in the management o..:

Shah, R. ; Ali, F. M. ; Finlay, A. Y..
Health and Quality of Life Outcomes.  19 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
12

Clinical experience and psychometric properties of the Card..:

Abdelrazik, Y.T. ; Ali, F.M. ; Salek, M.S..
British Journal of Dermatology.  185 (2021)  4 - p. 711-724 , 2021
Link: https://doi.org/10.1111/..
 
?
13

Topical preparations for the treatment of mild‐to‐moderate ..:

Stuart, B. ; Maund, E. ; Wilcox, C....
British Journal of Dermatology.  185 (2021)  3 - p. 512-525 , 2021
Link: https://doi.org/10.1111/..
 
?
14

Correction to: Family reported outcomes, an unmet need in t..:

Shah, R. ; Ali, F. M. ; Finlay, A. Y..
Health and Quality of Life Outcomes.  19 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
15

Why we should abandon the misused descriptor 'erythema':

Finlay, A.Y. ; Griffiths, T.W. ; Belmo, S..
British Journal of Dermatology.  185 (2021)  6 - p. 1240-1241 , 2021
Link: https://doi.org/10.1111/..
 
1-15